At 31.9x earnings with a Forward P/E of 16.1, the market is clearly pricing in a near-term earnings normalization, yet the 2.9 PEG suggests that growth is not compelling enough to justify a premium multiple. The 1.3 Price/Book and 0.7 Price/Sales imply surface-level value, but the Altman Z-Score of 1.1 signals financial stress risk that cannot be ignored. A Piotroski F-Score of 2 reinforces deteriorating fundamentals, meaning this is not a clean deep-value setup. The market is discounting balance sheet fragility and weak profitability, and based strictly on these metrics, that caution appears justified rather than irrational.